Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 85/100
Back to the Transcripts List

Axonics Modulation Technologies Inc at Bank of America Merrill Lynch Health Care Conference Transcript

May 15, 2019 / 05:15PM GMT
Release Date Price: $31.73 (+0.92%)
Raymond W. Cohen
Axonics Modulation Technologies, Inc. - CEO & Director

Good morning. My name is Raymond Cohen. I'm the Chief Executive Officer and Co-Founder of Axonics Modulation Technologies. We are pleased to be here at the BofA Conference today and appreciate for people to attend the session and for listening in on the webcast.

So just briefly in terms of a bit of an overview on Axonics. We are focused on the market of Sacral Neuromodulation. This is primarily a woman's health issue. There are approximately 47 million women who are suffering from either urinary or fecal incontinence or some variation of that theme. Sacral Neuromodulation has been around for a long time. It's fully reimbursed in the United States by Medicare and all private insurance carriers. Medtronic is currently the only player in the marketplace. And Axonics has come onto the scene here with the first and only rechargeable system that is designed to last at least 15 years in the body. This is important because the incumbent has a nonrechargeable device that needs to get explanted on average every 3 to 5 years. So we

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.